ISPOR’s CEO and Executive Director Announces Retirement

Published Jun 8, 2022


Nancy S. Berg Has Led the Society for Almost 8 Years

8x10_Berg-Nancy_925A0910Lawrenceville, NJ, USA—June 8, 2022—ISPOR—The Professional Society for Health Economics and Outcomes Research announced that its CEO and Executive Director, Nancy S. Berg, will be retiring. Ms Berg has led the Society for almost 8 years and has guided ISPOR’s growth and expanded influence globally. She will be retiring at the end of this year and working closely with the Board of Directors to ensure a smooth transition.

Ms Berg has led 3 global associations as CEO and has worked in professional membership societies for more than 40 years. During Ms Berg’s tenure, ISPOR has achieved many accomplishments and is poised to continue fulfilling its mission at the next level. Under her leadership, the Society has established and begun execution of its Strategic Plan Update 2024 and Science Strategy. ISPOR also underwent a rebranding to better reflect the organization’s role on the global stage. Ms Berg led the establishment of critical technology infrastructure, systems, processes, and business planning practices that are now mainstays of the organization. She drove the transition of ISPOR’s governance and progressive norms to ensure diversity and representation across stakeholders in the Society. Ms Berg also leaves ISPOR in a strong financial position, enabling the Society to continue its vital work despite the significant impact the pandemic has had of preventing organizations from organizing in-person conferences and events for the past 2 years.

While leading ISPOR, both Ms Berg and ISPOR received numerous awards. She was named a PharmaVOICE 100 most inspiring leader 3 times, a PharmaVOICE Red Jacket lifetime achievement awardee, and a PM360 Elite honoree, and has won a number of Stevie awards. ISPOR was also awarded dozens of awards for its rebranding campaign and website redesign.

“Leading ISPOR for these past 8 years has been a privilege and a pleasure,” stated Ms Berg. “While adjusting to retirement is going to take some time, I am thrilled by the opportunity to shift my attention away from a long and rigorous career and am looking forward to spending time with my husband and family. ISPOR has a meaningful mission and an all-star membership. I am pleased to have played a small part in the organization’s success.”

ISPOR’s Executive Committee—President Isao Kamae, MD, DrPH; President-Elect Jan Elias Hansen, PhD; Treasurer Sean D. Sullivan, BScPharm, MSc, PhD; Past President Jens Grueger, PhD; and newly elected President-Elect Brian O’Rourke, PharmD—will serve as the core Search Committee for Ms Berg’s successor. Drs Jan Hansen and Jens Grueger will guide the Search Committee as Co-Chairs toward the objective of hiring a new Executive Director by year end. An executive search firm will be engaged to support the search and selection process.


ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

ISPOR Announces 2024-2025 Board of Directors

May 28, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the results of its recent elections. The Society’s membership selected its new president-elect and 4 new board members. The 2024-2025 board will assume office on July 1.

Mitch Higashi, PhD Joins ISPOR as Associate Chief Science Officer

Dec 11, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that Mitch Higashi, PhD has joined the Society’s leadership team as Associate Chief Science Officer.

ISPOR Announces New Chief Science Officer

Aug 28, 2023

ISPOR announced that Laura Pizzi, PharmD, MPH will be assuming the role of Chief Science Officer at the Society. ISPOR’s previous Chief Science Officer, Richard J. Willke, PhD, will be retiring.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now